Related references
Note: Only part of the references are listed.Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
Vatche Tchekmedyian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Reassessing the Potential of Myb-targeted Anti-cancer Therapy
Xiaofeng Liu et al.
JOURNAL OF CANCER (2018)
A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma
Patrick M. Dillon et al.
CLINICAL CANCER RESEARCH (2017)
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
S. J. Wong et al.
ANNALS OF ONCOLOGY (2016)
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
A. L. Ho et al.
ANNALS OF ONCOLOGY (2016)
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L. D. Locati et al.
EUROPEAN JOURNAL OF CANCER (2016)
Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem
Moran Amit et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2016)
Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma.
Alan Loh Ho et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma
Bhumsuk Keam et al.
CANCER (2015)
Phase II study of gefitinib in patients with advanced salivary gland cancers
John A. Jakob et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
David J. Thomson et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Clinicopathological study of distant metastases of salivary adenoid cystic carcinoma
M. Gao et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2013)
The mutational landscape of adenoid cystic carcinoma
Allen S. Ho et al.
NATURE GENETICS (2013)
Risk Factors for Hemorrhage After Chemoradiation for Oropharyngeal Squamous Cell Carcinoma
Elizabeth M. Self et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2013)
Rare cancers of the head and neck area in Europe
B. A. C. Van Dijk et al.
EUROPEAN JOURNAL OF CANCER (2012)
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
Scott A. Laurie et al.
LANCET ONCOLOGY (2011)
A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands
M. Raphael Pfeffer et al.
ORAL ONCOLOGY (2007)
Health-related quality of life five years after diagnosis of laryngeal carcinoma
M Nordgren et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Share Paper
